Literature DB >> 12624141

Cancer risk in 348 French MSH2 or MLH1 gene carriers.

Y Parc, C Boisson, G Thomas, S Olschwang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12624141      PMCID： PMC1735402          DOI： 10.1136/jmg.40.3.208

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  18 in total

1.  Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.

Authors:  M M Blokhuis; G E Pietersen; P A Goldberg; U Algar; L Van der Merwe; N Mbatani; A A Vorster; R S Ramesar
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

Review 2.  The tumor spectrum in the Lynch syndrome.

Authors:  Patrice Watson; Bronson Riley
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Is surveillance of the small bowel indicated for Lynch syndrome families?

Authors:  G L ten Kate; J H Kleibeuker; F M Nagengast; M Craanen; A Cats; F H Menko; H F A Vasen
Journal:  Gut       Date:  2007-04-04       Impact factor: 23.059

4.  Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer: identical germline mutations associated with variable tumour morphology and immunohistochemical expression.

Authors:  Britta Halvarsson; Wolfram Müller; Maria Planck; Anna Clara Benoni; Peter Mangell; Johan Ottosson; Magnus Hallén; Anna Isinger; Mef Nilbert
Journal:  J Clin Pathol       Date:  2006-08-10       Impact factor: 3.411

5.  Epidemiology of cancer of the small intestine.

Authors:  Sai Yi Pan; Howard Morrison
Journal:  World J Gastrointest Oncol       Date:  2011-03-15

6.  Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome.

Authors:  Lucía Pérez-Cabornero; Mar Infante; Eladio Velasco; Enrique Lastra; Cristina Miner; Mercedes Durán
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571

7.  Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.

Authors:  Sylviane Olschwang; Kai Yu; Christine Lasset; Stéphanie Baert-Desurmont; Marie-Pierre Buisine; Qing Wang; Pierre Hutter; Etienne Rouleau; Olivier Caron; Violaine Bourdon; Gilles Thomas
Journal:  J Cancer Epidemiol       Date:  2009-03-08

8.  Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation.

Authors:  D A Stupart; P A Goldberg; U Algar; R Ramesar
Journal:  Fam Cancer       Date:  2009-08-18       Impact factor: 2.375

9.  Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.

Authors:  Yun-Hee Choi; Michelle Cotterchio; Gail McKeown-Eyssen; Monga Neerav; Bharati Bapat; Kevin Boyd; Steven Gallinger; John McLaughlin; Melyssa Aronson; Laurent Briollais
Journal:  Hered Cancer Clin Pract       Date:  2009-08-23       Impact factor: 2.857

10.  Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

Authors:  Karen A Kopciuk; Yun-Hee Choi; Elena Parkhomenko; Patrick Parfrey; John McLaughlin; Jane Green; Laurent Briollais
Journal:  Hered Cancer Clin Pract       Date:  2009-10-28       Impact factor: 2.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.